查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
欧洲内皮功能障碍市场预测至 2028 年 - 区域分析 - 按原因、测试类型和最终用户
市场调查报告书
商品编码
1420177

欧洲内皮功能障碍市场预测至 2028 年 - 区域分析 - 按原因、测试类型和最终用户

Europe Endothelial Dysfunction Market Forecast to 2028 - Regional Analysis - by Cause, Test Type, and End User
出版日期: | 出版商: The Insight Partners | 英文 122 Pages | 订单完成后即时交付

价格

欧洲内皮功能障碍市场预计将从2022年的6.1128亿美元成长到2028年的7.7637亿美元。预计2022年至2028年CAGR为4.1%。

高胆固醇、糖尿病和肥胖发病率上升推动欧洲内皮功能障碍市场

生活型态的改变导致糖尿病、高血压、血脂异常和肥胖的发生率上升，增加内皮功能障碍的机会。然而，这些可以透过主动监测、早期诊断和身体活动来预防。代谢症候群是一组会增加 CAD、糖尿病、高血压和其他严重健康问题风险的疾病。 2 型糖尿病已经是一个主要的公共卫生问题，并且在与肥胖相关的儿童和年轻人中发病率越来越高。根据世界卫生组织（WHO）的数据，2019年糖尿病是导致150万人死亡的直接原因，而所有糖尿病死亡人数的48%发生在70岁之前。另有46万人因肾臟病死亡是由糖尿病引起的。血糖升高导致约 20% 的心血管死亡。

高血压是全世界心血管疾病和过早死亡的主要原因。根据对人口中高血压盛行率、检测、治疗和控制趋势的首次全面全球分析，过去 30 年中，30-79 岁的成年人患有高血压的人数已从 6.5 亿增加到 12.8 亿。由伦敦由帝国学院和世界卫生组织制定。

欧洲内皮功能障碍市场概述

欧洲的内皮功能障碍市场细分为英国、德国、义大利、法国、西班牙和欧洲其他地区。心血管疾病盛行率的上升、人口老化的增加以及研发活动的增加是促进该地区市场成长的关键因素。此外，产品发布和政府投资将促进预测期内的市场成长。

欧洲内皮功能障碍市场收入及 2028 年预测（百万美元）

欧洲内皮功能障碍市场细分

欧洲内皮功能障碍市场按原因、测试类型、最终用户和国家细分。

根据病因，欧洲内皮功能障碍市场分为高血压、高胆固醇血症、肥胖、糖尿病、白塞氏症等。 2022 年，高血压细分市场在欧洲内皮功能障碍市占率最大。

根据测试类型，欧洲内皮功能障碍市场分为侵入性测试和非侵入性测试。到2022 年，侵入性测试细分市场将占据更大的欧洲内皮功能障碍市场。非侵入性测试细分市场进一步细分为血流介导的扩张、週边动脉张力测定(PAT)、静脉闭塞体积描记术、循环标记物等。

根据最终用户，欧洲内皮功能障碍市场分为医院、诊断中心、诊所等。到 2022 年，医院细分市场将占据欧洲最大的内皮功能障碍市场。

根据国家/地区，欧洲内皮功能障碍市场分为英国、德国、义大利、法国、西班牙和欧洲其他地区。德国在 2022 年主导欧洲内皮功能障碍市场。

ZOLL Medical Corp、Sphingo Tec GmbH、The Polymath Co、SMART Medical Ltd、Alam Medical SaRl 和 Medizinische Messtechnik GmbH 是该地区内皮功能障碍市场的一些领先公司。

目录

第 1 章：简介

  • 研究范围
  • Insight Partners 研究报告指南
  • 市场区隔
    • 欧洲内皮功能障碍市场 - 按原因分类
    • 欧洲内皮功能障碍市场 - 按测试类型
    • 欧洲内皮功能障碍市场 - 按最终用户分类
    • 欧洲内皮功能障碍市场 - 按国家/地区

第 2 章：欧洲内皮功能障碍市场 - 要点

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：欧洲内皮功能障碍市场 - 市场格局

  • 概述
  • PEST分析
    • 欧洲PEST分析
  • 专家意见

第 5 章：欧洲内皮功能障碍市场 - 主要市场动态

  • 市场驱动因素
    • 心血管疾病发生率增加
    • 高胆固醇、糖尿病和肥胖症的发生率上升
  • 市场限制
    • 内皮功能障碍筛检技术的缺点
  • 市场机会
    • 新型生物标记和治疗策略的使用不断增加
  • 未来的趋势
    • 使用非侵入性方法评估内皮功能障碍
  • 影响分析

第 6 章：内皮功能障碍市场 - 欧洲分析

  • 欧洲内皮功能障碍市场收入预测与分析

第 7 章：欧洲内皮功能障碍市场分析 - 按原因

  • 概述
  • 欧洲内皮功能障碍市场，依原因划分，2022 年和 2028 年 (%)
  • 高血压
  • 糖尿病
  • 高胆固醇血症
  • 白塞氏症
  • 肥胖
  • 其他的

第 8 章：欧洲内皮功能障碍市场分析 - 按测试类型

  • 概述
  • 欧洲内皮功能障碍市场，依测试类型，2022 年和 2028 年 (%)
  • 侵入性测试
  • 非侵入性测试

第 9 章：欧洲内皮功能障碍市场分析 - 按最终用户

  • 概述
  • 欧洲内皮功能障碍市场，依最终使用者划分，2022 年和 2028 年 (%)
  • 医院
  • 诊断中心
  • 诊所
  • 其他的

第 10 章：欧洲内皮功能障碍市场 - 收入和 2028 年预测 - 国家分析

  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区

第 11 章：欧洲内皮功能障碍市场-产业格局

  • 概述
  • 内皮功能障碍市场的成长策略
  • 无机成长策略
    • 概述
  • 有机成长策略
    • 概述

第 12 章：公司简介

  • ZOLL Medical Corp
  • Sphingo Tec GmbH
  • The Polymath Co
  • SMART Medical Ltd
  • Alam Medical SaRl
  • Medizinische Messtechnik GmbH

第 13 章：附录

  • 关于 Insight Partners
  • 专业术语
Product Code: BMIRE00029139

The Europe endothelial dysfunction market is expected to grow from US$ 611.28 million in 2022 to US$ 776.37 million by 2028. It is estimated to grow at a CAGR of 4.1% from 2022 to 2028.

Rising Incidences of High Cholesterol, Diabetes and Obesity Fuels Europe Endothelial Dysfunction Market

Lifestyle changes lead to a rise in the incidences of diabetes, hypertension, dyslipidemia, and obesity, increasing the chances of endothelial dysfunction. However, these can be prevented through proactive monitoring, early diagnosis, and physical activity. Metabolic syndrome is a group of disorders that increases the risk of CAD, diabetes, high blood pressure, and other serious health problems. Type 2 diabetes is already a major public health problem and is increasingly rising among the children and young adults associated with obesity. According to the World Health Organization (WHO), diabetes was the direct cause of 1.5 million deaths in 2019, and 48% of all deaths from diabetes occurred before age 70. Another 460,000 deaths from kidney disease were caused by diabetes. Elevated blood sugar causes ~20% of cardiovascular deaths.

Hypertension is the leading cause of cardiovascular disease and premature death worldwide. The number of adults aged 30-79 with hypertension has increased from 650 million to 1.28 billion over the past 30 years, according to the first comprehensive global analysis of trends in the prevalence, detection, treatment, and control of hypertension among the population, headed by Imperial College London and WHO.

Europe Endothelial Dysfunction Market Overview

The endothelial dysfunction market in Europe is sub-segmented into the UK, Germany, Italy, France, Spain, and the Rest of Europe. The rising prevalence of cardiovascular diseases, an increase in the aging population, and a growing number of research and development activities are the key factors contributing to the market growth in the region. Further, product launches and government investments would facilitate the market growth during the forecast period.

Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Europe Endothelial Dysfunction Market Segmentation

The Europe endothelial dysfunction market is segmented into cause, test type, end user, and country.

Based on cause, the Europe endothelial dysfunction market is segmented into hypertension, hypercholesterolaemia, obesity, diabetes, behcet's disease, and others. The hypertension segment registered the largest Europe endothelial dysfunction market share in 2022.

Based on test type, the Europe endothelial dysfunction market is segmented into invasive test and non-invasive test. The invasive test segment held a larger Europe endothelial dysfunction market share in 2022. The non-invasive test segment is further subsegmented into flow mediated dilatory, peripheral arterial tonometry (PAT), venous occlusion pletismography, circulating markers, and others.

Based on end user, the Europe endothelial dysfunction market has been categorized into hospitals, diagnostic centers, clinics, and others. The hospitals segment held the largest Europe endothelial dysfunction market share in 2022.

Based on country, the Europe endothelial dysfunction market is segmented into the UK, Germany, Italy, France, Spain, and the Rest of Europe. Germany dominated the Europe endothelial dysfunction market in 2022.

ZOLL Medical Corp, Sphingo Tec GmbH, The Polymath Co, SMART Medical Ltd, Alam Medical SaRl, and Medizinische Messtechnik GmbH are some of the leading companies operating in the endothelial dysfunction market in the region.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe endothelial dysfunction market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe endothelial dysfunction market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the endothelial dysfunction market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Europe Endothelial Dysfunction Market - by Cause
    • 1.3.2 Europe Endothelial Dysfunction Market - by Test Type
    • 1.3.3 Europe Endothelial Dysfunction Market - by End User
    • 1.3.4 Europe Endothelial Dysfunction Market - by Country

2. Europe Endothelial Dysfunction Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Endothelial Dysfunction Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Europe PEST Analysis
  • 4.3 Expert Opinion

5. Europe Endothelial Dysfunction Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Incidences of Cardiovascular Diseases
    • 5.1.2 Rising Incidences of High Cholesterol, Diabetes And Obesity
  • 5.2 Market Restraints
    • 5.2.1 Disadvantages Associated with the Techniques for Screening of Endothelial Dysfunction
  • 5.3 Market Opportunities
    • 5.3.1 Rising Usage of Novel Biomarkers and Therapeutic Strategies
  • 5.4 Future Trends
    • 5.4.1 Use of Noninvasive Methods to Assess Endothelial Dysfunction
  • 5.5 Impact Analysis

6. Endothelial Dysfunction Market - Europe Analysis

  • 6.1 Europe Endothelial Dysfunction Market Revenue Forecast and Analysis

7. Europe Endothelial Dysfunction Market Analysis - by Cause

  • 7.1 Overview
  • 7.2 Europe Endothelial Dysfunction Market, By Cause, 2022 & 2028 (%)
  • 7.3 Hypertension
    • 7.3.1 Overview
    • 7.3.2 Hypertension: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Diabetes
    • 7.4.1 Overview
    • 7.4.2 Diabetes: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Hypercholestrolaemia
    • 7.5.1 Overview
    • 7.5.2 Hypercholestrolaemia: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.6 Behcet's Disease
    • 7.6.1 Overview
    • 7.6.2 Behcet's Disease: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.7 Obesity
    • 7.7.1 Overview
    • 7.7.2 Obesity: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.8 Others
    • 7.8.1 Overview
    • 7.8.2 Others: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

8. Europe Endothelial Dysfunction Market Analysis - by Test Type

  • 8.1 Overview
  • 8.2 Europe Endothelial Dysfunction Market, By Test Type, 2022 & 2028 (%)
  • 8.3 Invasive Tests
    • 8.3.1 Overview
    • 8.3.2 Invasive Tests: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Non-Invasive Tests
    • 8.4.1 Overview
    • 8.4.2 Non-Invasive Tests: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.3 Flow Mediated Dilatory
      • 8.4.3.1 Overview
      • 8.4.3.2 Flow Mediated Dilatory: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.4 Venous Occlusion Plethysmography
      • 8.4.4.1 Overview
      • 8.4.4.2 Venous Occlusion Plethysmography: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.5 Peripheral Arterial Tonometry (PAT)
      • 8.4.5.1 Overview
      • 8.4.5.2 Peripheral Arterial Tonometry (PAT): Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.6 Circulating Markers
      • 8.4.6.1 Overview
      • 8.4.6.2 Circulating Markers: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.7 Others
      • 8.4.7.1 Overview
      • 8.4.7.2 Others: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

9. Europe Endothelial Dysfunction Market Analysis - by End User

  • 9.1 Overview
  • 9.2 Europe Endothelial Dysfunction Market, By End User, 2022 & 2028 (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Diagnostics Centers
    • 9.4.1 Overview
    • 9.4.2 Diagnostics Centers: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Clinics
    • 9.5.1 Overview
    • 9.5.2 Clinics: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

10. Europe Endothelial Dysfunction Market - Revenue and Forecast to 2028 - Country Analysis

  • 10.1 Europe: Endothelial Dysfunction Market
    • 10.1.1 Overview
      • 10.1.1.1 Germany: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 Germany: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.3 Germany: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.1.1.4 Germany: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.1.1.1.4.1 Germany: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.1.5 Germany: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.1.1.2 UK: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 UK: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.3 UK: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.1.2.4 UK: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.1.1.2.4.1 UK: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.2.5 UK: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.1.1.3 France: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 France: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.3 France: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.1.3.4 France: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.1.1.3.4.1 France: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.3.5 France: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.1.1.4 Italy: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 Italy: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.4.3 Italy: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.1.4.4 Italy: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.1.1.4.4.1 Italy: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.4.5 Italy: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.1.1.5 Spain: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.5.1 Overview
        • 10.1.1.5.2 Spain: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.5.3 Spain: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.1.5.4 Spain: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.1.1.5.4.1 Spain: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.5.5 Spain: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.1.1.6 Rest of Europe: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.6.1 Overview
        • 10.1.1.6.2 Rest of Europe: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.6.3 Rest of Europe: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.1.6.4 Rest of Europe: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.1.1.6.4.1 Rest of Europe: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.6.5 Rest of Europe: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)

11. Europe Endothelial Dysfunction Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Endothelial Dysfunction Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 ZOLL Medical Corp
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Sphingo Tec GmbH
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 The Polymath Co
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 SMART Medical Ltd
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Alam Medical SaRl
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Medizinische Messtechnik GmbH
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Techniques Used in to Assess Endothelial Function
  • Table 2. Novel Soluble and Cell Component Biomarkers of Endothelia Dysfunction in Cardiovascular Diseases
  • Table 3. Germany Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. Germany Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. Germany Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. Germany Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. UK Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. UK Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. UK Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. UK Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. France Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. France Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. France Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. France Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Italy Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Italy Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Italy Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Italy Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. Spain Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 20. Spain Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 21. Spain Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 22. Spain Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 23. Rest of Europe Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 24. Rest of Europe Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 25. Rest of Europe Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 26. Rest of Europe Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 27. Recent Inorganic Growth Strategies in the Endothelial Dysfunction Market
  • Table 28. Recent Organic Growth Strategies in the Endothelial Dysfunction Market
  • Table 29. Glossary of Terms, Endothelial dysfunction market

List Of Figures

  • Figure 1. Europe Endothelial Dysfunction Market Segmentation
  • Figure 2. Europe Endothelial Dysfunction Market, by Country
  • Figure 3. Europe Endothelial Dysfunction Market Overview
  • Figure 4. Hypertension Account for Largest Share of Cause Segment in Europe Endothelial Dysfunction Market
  • Figure 5. Germany Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. Europe: PEST Analysis
  • Figure 7. Expert Opinion
  • Figure 8. Europe Endothelial Dysfunction Market: Impact Analysis of Drivers and Restraints
  • Figure 9. Europe Endothelial Dysfunction Market - Revenue Forecast and Analysis - 2020-2028
  • Figure 10. Europe Endothelial Dysfunction Market, by Cause, 2022 & 2028 (%)
  • Figure 11. Hypertension: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 12. Diabetes: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Hypercholestrolaemia: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. Behcet's disease: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 15. Obesity: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. Others: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. Europe Endothelial Dysfunction Market, by Test Type, 2022 & 2028 (%)
  • Figure 18. Invasive Tests: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 19. Non-Invasive Tests: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Flow Mediated Dilatory: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Venous Occlusion Plethysmography: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Peripheral Arterial Tonometry (PAT): Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Circulating Markers: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Others: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Europe Endothelial Dysfunction Market, by End User, 2022 & 2028 (%)
  • Figure 26. Hospitals and Clinics: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Diagnostics Centers: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Clinics: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Others: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. Europe: Endothelial Dysfunction Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 31. Europe: Endothelial Dysfunction Market, by Country, 2022 & 2028 (%)
  • Figure 32. Germany: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 33. UK: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 34. France: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 35. Italy: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 36. Spain: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 37. Rest of Europe: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 38. Growth Strategies in the Endothelial Dysfunction Market